CĂRȚI ÎN ENGLEZĂ ÎN LEGĂTURĂ CU «ONCOLYSIS»
Descoperă întrebuințarea
oncolysis în următoarea selecție bibliografică. Cărți în legătură cu
oncolysis și extrase din aceasta pentru a furniza contextul de întrebuințare al acestuia în literatura Engleză.
1
Cellular Targets Involved in Reovirus-induced
Oncolysis of ...
Reovirus is a ubiquitous virus with demonstrated oncolytic properties.
2
The Use of Vaccinia Virus E3L Amino-terminal Mutants in ...
Oncolytic viruses have promise as cancer therapeutics due to their targeted
nature and ability to destroy cancer cells through oncolysis and/or necrosis (31 ,
44, 55). One targeting strategy that has proven successful in a variety of oncolytic
...
3
Mechanisms of Resistance to Reoviral
Oncolysis
We have asked whether Ras-oncogenic human cancer cells can acquire resistance to reoviral oncolysis.
4
Reovirus
Oncolysis and Determinants of Susceptibility
Reovirus represents a promising novel anti-cancer therapeutic and is presently being investigated in clinical trials for the treatment of diverse human cancers.
5
Neurotropic Viral Infections
“Viral oncolysis” refers to the ability of some viruses
directlytokillcancercellsbyinfectingthem,replicat- ing intracellularly, and then
lysing the cells as infectious viral progeny are released and subsequently infect
surrounding cancer cells.
Carol Shoshkes Reiss, 2008
6
Gene Therapy and Cancer Research Focus
63(1960) 447-455 [19] R. Carey, Clostridial oncolysis in man, Proc Amer Ass
Cancer Res 1965; 6. [20] Carey R. Clostridial oncolysis in man. European
Journal of Cancer 1967; 3: 37-46. [21] Heppner F, Mose JR. The liquefaction (
oncolysis) of ...
Rebecca N. Campbell, 2008
7
Vesicular Stomatitis: New Insights for the Healthcare ...
New research, 'Cell cycle progression or translation control is not essential for
vesicular stomatitis virus oncolysis of hepatocellular carcinoma,' is the subject of
a report. “The intrinsic oncolytic specificity of vesicular stomatitis virus (VSV) is ...
8
Biomedical Materials and Diagnostic Devices
Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55) and other
nonpathogenic clostridia against the Ehrlich carcinoma. Cancer Res. 1964, 24,
212-216. D. Gericke, F. Dietzel, I. Ruster. Further progress with oncolysis due to
local ...
Ashutosh Tiwari, Murugan Ramalingam, Hisashi Kobayashi, 2012
Mose, J. R. and Mose, G. (1964) Oncolysis by clostridia. I. Activity of Clostridium
butyricum (M-55) and other nonpathogenic clostridia against the Ehrlich
carcinoma. Cancer Res. 24, 212–216. Thiele, E. H., Arison, R. N., and Boxer,
G. E. (1964) ...
David T. Curiel, Joanne T. Douglas, 2007
10
Advances in Nucleocapsid Research and Application: 2011 ...
Current study results from the report, 'Viral oncolysis that targets Raf-l signaling
control of nuclear transport,' have been published. According to recent research
from Cantoblanco, Spain, “The central role of Raf protein kinase isoforms in ...
ȘTIRI NOI CARE INCLUD TERMENUL «ONCOLYSIS»
Află ce ziare naționale și internaționale au scris despre și cum este întrebuințat termenul
oncolysis în contextul următoarelor știri.
Hope4Cancer Offers Rigvir Virotherapy, a New Cancer Treatment
The virus enters and then multiplies within these cancer cells through a process called oncolysis, which destroys them. At the same time, the ... «Benzinga, Iul 15»
Oncolytics: Killing Cancer With A Virus
Viral oncolysis is already approved in China, but not so in the West. A single approval will break the barrier, so to say. Thirdly, these therapies ... «Seeking Alpha, Iul 15»
Interferon Beta and Interferon Alpha 2a Differentially Protect Head …
Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis. «Journal of Virology, Iul 15»
Stock Update (NASDAQ:ONCY): Oncolytics Biotech, Inc. (USA …
The second abstract/poster titled “Oncolysis by reovirus as an immune priming mechanism with VSV-cDNA immunological boosting treats large ... «Smarter Analyst, Iun 15»
ORYX's oncolytic parvovirus H1 successfully completes Phase I/IIa …
In addition, viral oncolysis induces a strong and lasting tumour-specific immune response (bystander effect). Dr Bernard Huber, CEO and ... «European Pharmaceutical Review, Iun 15»
Cancer-Killing Virus Looks Promising
... the engineered virus pierces the protective shield surrounding cancer cells and produces proteins that cause the cell to burst (oncolysis). «MD Magazine, Mai 15»
Research and Markets: Global Drug Delivery in Cancer 2015-2024 …
These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine ... «Yahoo Finance UK, Mai 15»
A cross-talk network that facilitates tumor virotherapy
... including this induction of an anti-tumor immune response and direct oncolysis. However, this has not been shown to occur consistently and ... «Nature.com, Mai 15»
Global Drug Delivery in Cancer Report 2014 - Technologies …
These include antiangiogenic agents, immunotherapy, bacterial agents, viral oncolysis, targeting of cyclic-dependent kinases and tyrosine ... «PR Newswire, Nov 14»
Cold Genesys gets $13.6M Series A for oncolytic virus to treat …
... a point, they'll no longer have the capability to hold anymore of the virus, so oncolysis will happen and the tumor cells will burst,” Kuan said. «MedCity News, Iul 14»
